HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gavin Giovannoni Selected Research

Lymphopenia (Lymphocytopenia)

7/2021Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis.
1/2021Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets.
4/2019Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis.
1/2019Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies.
10/2018Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.
5/2018Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells.
1/2018Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
2/2010A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gavin Giovannoni Research Topics

Disease

184Multiple Sclerosis
11/2022 - 10/2002
56Relapsing-Remitting Multiple Sclerosis
06/2022 - 09/2003
16Chronic Progressive Multiple Sclerosis
09/2022 - 09/2003
16Disease Progression
10/2019 - 10/2004
12Infections
11/2021 - 02/2012
10Atrophy
01/2022 - 12/2010
10Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2017 - 05/2005
9COVID-19
08/2022 - 01/2020
9Demyelinating Diseases (Demyelinating Disease)
06/2022 - 04/2003
8Inflammation (Inflammations)
06/2022 - 05/2005
8Lymphopenia (Lymphocytopenia)
07/2021 - 02/2010
6Neurodegenerative Diseases (Neurodegenerative Disease)
06/2022 - 01/2010
6Autoimmune Diseases (Autoimmune Disease)
01/2022 - 04/2007
6Neoplasms (Cancer)
01/2020 - 01/2017
6Movement Disorders (Movement Disorder)
11/2014 - 08/2004
5Progressive Multifocal Leukoencephalopathy
01/2022 - 04/2010
5Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2020 - 03/2014
5Nervous System Diseases (Neurological Disorders)
11/2014 - 11/2006
5Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
05/2012 - 08/2004
5Chorea (Rheumatic Chorea)
04/2009 - 03/2003
4Infectious Mononucleosis (Glandular Fever)
10/2020 - 01/2009
4Neuromyelitis Optica (Devic's Disease)
09/2020 - 01/2011
4Herpes Zoster
04/2019 - 02/2010
4Parkinson Disease (Parkinson's Disease)
01/2018 - 05/2008
4Streptococcal Infections (Streptococcal Infection)
05/2012 - 08/2004
3Epstein-Barr Virus Infections
01/2022 - 06/2007
3Headache (Headaches)
07/2021 - 11/2014
3Chickenpox
01/2019 - 01/2009
3Hypersensitivity (Allergy)
01/2019 - 03/2006
3Neuroinflammatory Diseases
01/2017 - 01/2011
3Optic Neuritis (Retrobulbar Neuritis)
03/2016 - 06/2008
3Encephalitis (Encephalitis, Rasmussen)
08/2010 - 01/2004
2Rheumatoid Arthritis
08/2021 - 07/2012
2Nausea
07/2021 - 09/2012
2Opportunistic Infections (Opportunistic Infection)
04/2019 - 11/2018
2Human Influenza (Influenza)
01/2019 - 01/2004
2Meningitis
01/2019 - 08/2010
2Urinary Tract Infections (Urinary Tract Infection)
01/2019 - 07/2016
2HIV Infections (HIV Infection)
08/2018 - 01/2015
2Vitamin D Deficiency
02/2018 - 07/2013
2Hypertension (High Blood Pressure)
01/2018 - 12/2012
2Spinal Cord Injuries (Spinal Cord Injury)
01/2018 - 03/2015
2Body Weight (Weight, Body)
01/2018 - 02/2010
2Ulcerative Colitis
07/2016 - 07/2012
2Exanthema (Rash)
03/2016 - 06/2013

Drug/Important Bio-Agent (IBA)

31CladribineFDA LinkGeneric
06/2022 - 02/2010
29AntibodiesIBA
11/2021 - 11/2003
26Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2006
22TabletsIBA
06/2022 - 02/2010
18Alemtuzumab (Campath)FDA Link
01/2022 - 03/2012
18Natalizumab (Tysabri)FDA Link
01/2022 - 03/2006
15Dimethyl FumarateIBA
01/2018 - 09/2012
14Fingolimod Hydrochloride (FTY720)FDA Link
08/2022 - 07/2011
13InterferonsIBA
01/2021 - 09/2004
13Interferon beta-1aFDA Link
01/2018 - 10/2004
12Interferon-betaIBA
01/2015 - 09/2003
11Monoclonal AntibodiesIBA
11/2022 - 03/2012
11Vitamin DFDA LinkGeneric
01/2020 - 06/2007
10Pharmaceutical PreparationsIBA
01/2022 - 05/2010
8ocrelizumabIBA
10/2022 - 01/2017
8siponimodIBA
09/2022 - 02/2017
8Proteins (Proteins, Gene)FDA Link
08/2021 - 12/2008
8Daclizumab (Zenapax)FDA Link
10/2020 - 06/2013
8CannabinoidsIBA
08/2017 - 05/2003
7Neutralizing AntibodiesIBA
11/2021 - 06/2007
7GadoliniumIBA
01/2020 - 07/2006
6AntigensIBA
11/2021 - 05/2005
5VaccinesIBA
08/2022 - 06/2020
5HLA-DRB1 Chains (HLA DRB1)IBA
10/2020 - 01/2010
5Immunoglobulin G (IgG)IBA
01/2013 - 01/2003
4Sphingosine-1-Phosphate ReceptorsIBA
09/2022 - 07/2011
4Neuroprotective AgentsIBA
01/2020 - 01/2013
4Glatiramer Acetate (Copaxone)FDA Link
02/2017 - 05/2005
4EnzymesIBA
07/2016 - 03/2006
4daclizumab HYPIBA
05/2014 - 06/2013
3Immunoglobulins (Immunoglobulin)IBA
01/2022 - 10/2019
3Indicators and Reagents (Reagents)IBA
08/2021 - 12/2014
3Oligoclonal BandsIBA
10/2019 - 04/2003
3Rituximab (Mabthera)FDA Link
02/2017 - 03/2016
3AutoantibodiesIBA
05/2015 - 03/2003
3Biological ProductsIBA
09/2014 - 07/2009
3Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
06/2013 - 08/2010
2opicinumabIBA
02/2022 - 01/2019
2Biotin (Vitamin H)FDA Link
02/2022 - 12/2020
2Cytidine Diphosphate (CDP)IBA
01/2022 - 12/2018
2COVID-19 VaccinesIBA
01/2022 - 01/2021
2AutoantigensIBA
11/2021 - 03/2006
2RNA (Ribonucleic Acid)IBA
10/2020 - 01/2004
2Transaminases (Aminotransferases)IBA
01/2018 - 09/2012
2Dopamine (Intropin)FDA LinkGeneric
01/2018 - 07/2009
2Minocycline (Cyclops)FDA LinkGeneric
01/2018 - 03/2015
2Gonadal HormonesIBA
11/2016 - 10/2014
2CytokinesIBA
04/2016 - 01/2013
2Sodium Channels (Sodium Channel)IBA
03/2016 - 01/2014
2Voltage-Gated Sodium ChannelsIBA
03/2016 - 06/2015
2Salivary Proteins and PeptidesIBA
12/2015 - 10/2015

Therapy/Procedure

60Therapeutics
10/2022 - 11/2003
7Immunotherapy
04/2021 - 05/2005
2Injections
11/2021 - 05/2018
2Precision Medicine
11/2021 - 11/2017